NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Jianpu Technology Inc. (JT)
Class Period: Pursuant and/or traceable to the initial public offering on or about November 16, 2017
Lead Plaintiff Deadline: December 24, 2018
Join the action: https://www.zlk.com/pslra-1/jianpu-technology-inc-loss-form?wire=3
The complaint alleges that the Company’s IPO offering materials contained inaccurate statements of material fact and/or omitted material information required to be disclosed in order to make such statements not misleading, including failure to disclose that the China Banking Regulatory Commission and three other Chinese regulators had issued rules in 2016 requiring peer-to-peer lending companies to appoint qualified banking institutions as custodians and disclose their use of deposits. On November 21, 2017, news outlets reported that China’s Financial Stability and Development Committee (“FSDC”) had issued an urgent notice to provincial governments urging them to suspend regulatory approval of new internet micro-loan companies. Following this news, Jianpu’s shares fell over 38% in three days and closed at $4.90 per share on November 24, 2017.
To learn more about the Jianpu Technology Inc. class action contact firstname.lastname@example.org.
Adient plc (ADNT)
Class Period: October 31, 2016 - June 11, 2018
Lead Plaintiff Deadline: December 3, 2018
Join the action: https://www.zlk.com/pslra-1/adient-plc-loss-form?wire=3
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements. In particular, the complaint alleges that defendants repeatedly stressed to investors that the Company was “solidly on track” to deliver 200-basis-point margin expansion by 2020, which was largely dependent on operational and financial improvements in Adient’s core SS&M business, while unbeknownst to investors, Adient’s core SS&M business faced significant operational problems such that the repeatedly touted 200-basis-point margin expansion was not “on track” at any point during the Class Period. Consequently, Adient stock traded at artificially inflated prices during the Class Period, reaching a high of $85.93 per share.
To learn more about the Adient plc class action contact email@example.com.
Evoqua Water Technologies Corp. (AQUA)
Class Period: November 6, 2017 - October 30, 2018
Lead Plaintiff Deadline: January 7, 2019
Join the action: https://www.zlk.com/pslra-1/evoqua-water-technologies-corp-loss-form?wire=3
About the lawsuit: Throughout the class period, Evoqua Water Technologies Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Evoqua failed to successfully integrate its prior acquisitions; (2) Evoqua was experiencing supply chain disruptions influenced by tariffs and an extended delay on a large aquatics project; and (3) as a result, Evoqua’s public statements were materially false and misleading at all relevant times.
To learn more about the Evoqua Water Technologies Corp. class action contact firstname.lastname@example.org.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171